Skip to content
10-K

Annual Report

XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

0001213900-20-013743

← back to feed
Filed
Jun 1, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · May 29, 2020 46.27M sh
Capex FY 2019 · Dec 31, 2019 $48.06K
Capex FY 2019 · Dec 31, 2018 $176.82K
Operating Cash Flow FY 2019 · Dec 31, 2019 −$10.67M
Operating Cash Flow restated FY 2019 · Dec 31, 2018 −$14.72M
Short Term Debt FY 2019 · Dec 31, 2019 $78.95K
Cash And Equivalents FY 2019 · Dec 31, 2019 $92.66K
Cash And Equivalents restated FY 2019 · Dec 31, 2018 $4.75M
Cash And Equivalents restated FY 2019 · Dec 31, 2017 $100.34K
Stockholders Equity FY 2019 · Dec 31, 2019 −$22.56M
Stockholders Equity restated FY 2019 · Dec 31, 2018 −$20.09M
Stockholders Equity restated FY 2019 · Dec 31, 2017 −$5.73M
Total Liabilities FY 2019 · Dec 31, 2019 $23.5M
Total Liabilities FY 2019 · Dec 31, 2018 $17.65M
Current Assets FY 2019 · Dec 31, 2019 $422.73K
Current Assets restated FY 2019 · Dec 31, 2018 $5.02M
Total Assets FY 2019 · Dec 31, 2019 $937.52K
Total Assets restated FY 2019 · Dec 31, 2018 $5.46M
Sga Expense FY 2019 · Dec 31, 2019 $12.92M
Sga Expense FY 2019 · Dec 31, 2018 $3.05M
Rd Expense FY 2019 · Dec 31, 2019 $12.09M
Rd Expense FY 2019 · Dec 31, 2018 $25.16M
Net Income FY 2019 · Dec 31, 2019 −$25.1M
Net Income restated FY 2019 · Dec 31, 2018 −$28.59M
Operating Income FY 2019 · Dec 31, 2019 −$25.04M
Operating Income restated FY 2019 · Dec 31, 2018 −$28.57M